Pingarrón-Ríos RA, Castorena-Arellano GA, Calderón-Vidal M

Language: Spanish
References: 26
Page: 288-294
PDF size: 193.03 Kb.

ABSTRACT

Neuroaxial regional anesthesia is an effective and safe method to provide adequate anesthesia and analgesia in the postoperative period. Reasons to receive neuroaxial anesthesia are diverse, but preoperative conditions, surgical trauma and prolonged postoperative rest, may produce a thromboembolic venous disease which constitutes the most frequent indication of anticoagulation in the perioperative period. In hospital thromboprophylaxis, enoxaparin, a low molecular weight heparin or similar drugs are the most commonly used anticoagulants. However, in the last decade the so-called «new oral anticoagulants» (NOAC) are also available. These are: direct inhibitors of thrombin (such as dabigatran) and factor Xa inhibitors (rivaroxaban and apixaban), with some advantages over low molecular weight heparins. The anesthesiologist should be aware of evidence-based recommendations for the proper management of the new oral anticoagulants in these patients.

REFERENCES

1. Secretaría de Salud. Guía de Práctica Clínica Diagnóstico y Tratamiento de la Enfermedad Tromboembólica Venosa. México: 2010.

2. Cabrera-Rayo A, Nellen-Hummel H. Epidemiología de la enfermedad tromboembólica venosa. Gac Med Mex. 2007;143:3-5.

3. Sierra-Juárez MA. Síndrome postrombótico. Panorama actual y revisión de la literatura. Rev Mex Angiol. 2010;38:102-107.

4. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:7S-47S.

5. Galván-Talamantes DY, Carrillo-Esper R. Reversión de la anticoagulación en cirugía de urgencia. Rev Mex Anestesiol. 2014;37:407-413.

6. National Clinical Guideline Centre. The management of hip fracture in adults. London: National Clinical Guideline Centre; 2011. pp. 1-628.

7. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321:1493.

8. Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Pract Res Clin Anaesthesiol. 2006;20:249-263.

9. Camacho del Angel JE. La anestesia regional en pacientes con trauma. Rev Mex Anestesiol. 2013;36:205-210.

10. Jabbari A, Alijanpour E, Mir M, Bani Hashem N, Rabiea SM, Rupani MA. Post spinal puncture headache, an old problem and new concepts: review of articles about predisposing factors. Caspian J Intern Med. 2013;4:595-602.

11. Berg AP, Rosenquist RW. Complications of peripheral nerve blocks. Tech Reg Anesth Pain Manag. 2007;11:133-140.

12. Green L, Machin SJ. Managing anticoagulated patients during neuraxial anaesthesia. Br J Haematol. 2010;149:195-208.

13. Cappelleri G, Fanelli A. Use of direct oral anticoagulants with regional anesthesia in orthopedic patients. J Clin Anesth. 2016;32:224-235.

14. Sánchez-Gutiérrez C, Alemán-Martín A, Coronado-Hijón V, Jiménez-Delgado P. Resolución espontánea de paraparesia por hematoma epidural dorsolumbar asociado a anestesia subaracnoidea y analgesia postoperatoria mediante catéter epidural. Rev Esp Anestesiol Reanim. 2012;59:503-506.

15. Claerhout AJ, Johnson M, Radtke JD, Zaglaniczny KL. AANA journal course. Update for nurse anesthetists. 2. Anticoagulation and spinal and epidural anesthesia. AANA J. 2004;72:225-231.

16. Flores-Rivera OI, Meza-Márquez JM, Nava-López JA, Ramírez-Morales K. Fisiología de la coagulación. Rev Mex Anestesiol. 2014;37:382-386.

17. Mateo J. Nuevos anticoagulantes orales y su papel en la práctica clínica. Rev Esp Cardiol Supl. 2013;13:33-41.

18. Llau JV, Ferrandis R, Castillo J, Andrés J, De Gomar C, Gómez-Luque A, et al. Manejo de los anticoagulantes orales de acción directa en el período perioperatorio y técnicas invasivas. Rev Esp Anestesiol Reanim. 2012;59:321-330.

19. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.

20. Benzon HT, Avram MJ, Green D, Bonow RO. New oral anticoagulants and regional anaesthesia. Br J Anaesth. 2013;111:i96-113.

21. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573-1579.

22. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413-2424.

23. Albaladejo P, Bonhomme F, Blais N, Collet JP, Faraoni D, Fontana P, et al. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015. Anaesth Crit Care Pain Med. 2017;36:73-76.

24. Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511-520.

25. Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010;27:999-1015.

26. Breivik H, Bang U, Jalonen J, Vigfússon G, Alahuhta S, Lagerkranser M. Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2010;54:16-41.